The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies.
about
Role of multifaceted regulators in cancer glucose metabolism and their clinical significancePan-cancer analysis for studying cancer stage using protein expression dataExpression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progressionMEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384.Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathwaysTDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathwayStabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers.Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.Defining the genomic landscape of head and neck cancers through next-generation sequencing.Two different protein expression profiles of oral squamous cell carcinoma analyzed by immunoprecipitation high-performance liquid chromatography.Could the PI3K canonical pathway be a common link between chronic inflammatory conditions and oral carcinogenesis?Glimpses of the near future: a new generation of mTOR inhibitors.Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinomaMicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.Developing a novel dual PI3K-mTOR inhibitor from the prodrug of a metabolite.Genomics and advances towards precision medicine for head and neck squamous cell carcinoma.Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma.Suppression of STIM1 inhibits the migration and invasion of human prostate cancer cells and is associated with PI3K/Akt signaling inactivation.PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.Precision Therapy of Head and Neck Squamous Cell Carcinoma.Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibition.Immunohistochemical evaluation of the mTOR pathway in intra-oral minor salivary gland neoplasms.NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin.
P2860
Q26765039-7F39461F-A6AA-4DD1-8B57-EBCE88265A4CQ31035525-B465DD1B-F7B9-41B1-87D5-F62FCC9CA179Q35101047-20302B46-A194-42BE-9247-7706B5A760D8Q35197507-D1CE4AFD-44CC-40DE-8C6A-063E6D83E35BQ35751948-0902B1BE-3183-449E-8DA0-6D6825F9CDF9Q35916084-4956DA5A-C0AB-4FAC-94B0-8BDBE40F6A3AQ36288650-C9C04A31-5772-4167-9BF7-819C6AFA096BQ36498943-2CA874D2-0FFB-46C4-BB62-C893128B6B61Q36542415-5360A972-7466-4290-BC5A-D807803DFE3AQ36612435-C3D6B79A-2DC4-486C-9360-EBFAD0F21318Q38203938-D4E6A451-9FF6-469D-9BEC-BCCE18DF4332Q38645330-AC930597-63F3-471F-AEA5-DEEAED395058Q38780033-63B83D8B-692B-4E1D-A0E4-E20D7FC772C9Q38799580-64C615A3-F3B6-4036-888E-3309F9DD7135Q39097109-17F55211-521C-48E9-9EF3-BF750E021218Q42323431-D5363B0B-BD67-48B1-A4B3-D1EB9933D50FQ44318431-61AD7278-17D3-4C7F-9F9C-451500BCDF98Q47098975-D4378EC2-1945-4E9E-86E3-CFEA7A4A10EEQ47202432-3CB33DF4-741B-4FFA-9275-07AC1B874FB9Q49480974-BA5AA662-C829-40AB-BB87-2B25D0D75BE2Q49887901-3BA9B33A-49E0-4A37-92E2-556621363B3CQ52591781-CD20F329-E6AF-4C1E-9F3F-AA410136BAEFQ53688963-2744C566-09B7-4CCA-9164-E36D516A6AAAQ54194644-9F8E415B-F74C-4375-9784-CA762AC5A366Q54979107-4781381D-273F-43AB-BC9D-B0EA105DE973
P2860
The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The PI3K/Akt/mTOR axis in head ...... ns, cross-talk, and therapies.
@en
type
label
The PI3K/Akt/mTOR axis in head ...... ns, cross-talk, and therapies.
@en
prefLabel
The PI3K/Akt/mTOR axis in head ...... ns, cross-talk, and therapies.
@en
P2093
P2860
P356
P1433
P1476
The PI3K/Akt/mTOR axis in head ...... ons, cross-talk, and therapies
@en
P2093
C Van Waes
R Vander Broek
P2860
P304
P356
10.1111/ODI.12206
P577
2013-12-23T00:00:00Z